Skip to main content
. Author manuscript; available in PMC: 2012 Apr 30.
Published in final edited form as: Leuk Lymphoma. 2011 Sep 13;53(1):166–168. doi: 10.3109/10428194.2011.606944

Figure 1.

Figure 1

Imiquimod alters human CTCL cell line viability. Cells were stimulated for 24, 48 or 72 h and stained with propidium iodide (PI) to measure the percentage of dead cells by flow cytometry. Error bars represent the standard deviation of values from three independent experiments.